Cambiar Investors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.9M Buy
612,194
+36,906
+6% +$2.98M 2.08% 15
2026
Q1
$49.8M Buy
575,288
+99
+0% +$9.48K 2.31% 14
2025
Q4
$55.3M Sell
575,189
-14,226
-2% -$1.38M 2.47% 7
2025
Q3
$56.1M Sell
589,415
-52,527
-8% -$4.83M 2.55% 4
2025
Q2
$56M Sell
641,942
-7,128
-1% -$604K 2.35% 11
2025
Q1
$58.3M Sell
649,070
-5,729
-0.9% -$513K 2.47% 6
2024
Q4
$52.3M Sell
654,799
-28,813
-4% -$2.49M 2.07% 16
2024
Q3
$61.5M Sell
683,612
-10,903
-2% -$917K 2.37% 5
2024
Q2
$54.7M Buy
694,515
+44,984
+7% +$3.69M 2.14% 12
2024
Q1
$56.6M Buy
649,531
+41,891
+7% +$3.58M 2.11% 12
2023
Q4
$50.1M Buy
607,640
+7,786
+1% +$593K 1.97% 16
2023
Q3
$47M Sell
599,854
-5,305
-0.9% -$444K 2% 14
2023
Q2
$53.3M Buy
605,159
+33,660
+6% +$2.9M 2.25% 4
2023
Q1
$46.1M Buy
571,499
+7,125
+1% +$581K 1.98% 15
2022
Q4
$43.9M Buy
564,374
+182,466
+48% +$14.8M 2% 17
2022
Q3
$30.8M Buy
381,908
+19,449
+5% +$1.75M 1.55% 27
2022
Q2
$32.5M Buy
362,459
+27,230
+8% +$2.76M 1.45% 30
2022
Q1
$37.2M Buy
335,229
+3,273
+1% +$346K 1.4% 32
2021
Q4
$34.3M Buy
331,956
+45,563
+16% +$5.28M 1.18% 43
2021
Q3
$35.9M Sell
286,393
-98,015
-25% -$12.7M 1.23% 37
2021
Q2
$47.7M Buy
384,408
+5,934
+2% +$745K 1.53% 30
2021
Q1
$44.7M Sell
378,474
-11,436
-3% -$1.34M 1.56% 26
2020
Q4
$45.7M Buy
389,910
+60,210
+18% +$6.63M 1.78% 20
2020
Q3
$34.3M Sell
329,700
-21,228
-6% -$2.13M 1.56% 23
2020
Q2
$32.2M Buy
350,928
+99,361
+39% +$9.53M 1.48% 26
2020
Q1
$22.7M Sell
251,567
-13,273
-5% -$1.41M 1.14% 37
2019
Q4
$30M Sell
264,840
-174,304
-40% -$19.1M 0.97% 41
2019
Q3
$47.7M Sell
439,144
-20,802
-5% -$2.17M 1.53% 13
2019
Q2
$44.8M Sell
459,946
-43,317
-9% -$3.95M 1.16% 24
2019
Q1
$45.8M Sell
503,263
-27,440
-5% -$2.46M 1.09% 22
2018
Q4
$48.3M Sell
530,703
-29,863
-5% -$2.79M 1.09% 21
2018
Q3
$55.1M Sell
560,566
-87,057
-13% -$8.05M 1% 26
2018
Q2
$55.4M Sell
647,623
-19,897
-3% -$1.66M 0.93% 28
2018
Q1
$53.5M Sell
667,520
-12,525
-2% -$1.03M 0.85% 29
2017
Q4
$54.9M Buy
+680,045
New +$54.5M 0.86% 32

Other funds holding MDT

Cambiar Investors's MDT Position: Q2 2026 in Review

Cambiar Investors increased its Medtronic (MDT) stake by 6.4% in Q2 2026, buying an estimated $2.98M and bringing the position to 612,194 shares worth $47.9M. The position accounts for 2.08% of the portfolio, ranked #15.

Cambiar Investors first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $61.5M in Q3 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cambiar Investors held 612,194 shares of Medtronic worth $47.9M as of Q2 2026.
  • Cambiar Investors bought 36,906 Medtronic shares in Q2 2026, an estimated $2.98M.
  • Medtronic made up 2.08% of Cambiar Investors's portfolio in Q2 2026, its #15 holding.
  • Cambiar Investors first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
  • Cambiar Investors's Medtronic position peaked at $61.5M in Q3 2024.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.